Home/Filings/4/0001209191-23-048125
4//SEC Filing

Shalev Varda 4

Accession 0001209191-23-048125

CIK 0000818686other

Filed

Sep 4, 8:00 PM ET

Accepted

Sep 5, 4:05 PM ET

Size

5.8 KB

Accession

0001209191-23-048125

Insider Transaction Report

Form 4
Period: 2023-09-02
Shalev Varda
Director
Transactions
  • Award

    Restricted Share Units

    2023-09-02+12,87212,872 total
    Ordinary Shares (12,872 underlying)
Footnotes (3)
  • [F1]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
  • [F2]Restricted share units were granted on September 2, 2023 and vest on September 2, 2024.
  • [F3]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Issuer

TEVA PHARMACEUTICAL INDUSTRIES LTD

CIK 0000818686

Entity typeother

Related Parties

1
  • filerCIK 0001873934

Filing Metadata

Form type
4
Filed
Sep 4, 8:00 PM ET
Accepted
Sep 5, 4:05 PM ET
Size
5.8 KB